On January 26th, the ground was officially broken for the expansion of the company Aseptic Technologies, located in the heart of the CREALYS science park in Gembloux-Les Isnes.
Two new buildings with a total area of 2500m² as well as 460 solar panels will complete the existing premises. The new construction accompanies the company’s strong growth.
In the science park since 2002, Aseptic Technologies is active in the pharmaceutical sector as a supplier of aseptic fill and finish solutions. This Belgian company is part of the Swiss group SKAN AG and has customers worldwide. In 2023, they will install their 500th equipment at one of their customers and increase their number of employees by 10%.
“This is a big step in the history of Aseptic Technologies,” says Patrick Balériaux, CEO at Aseptic Technologies.
The inauguration is scheduled for December 2023.
Aseptic Technologies develops and manufactures innovative equipment used for the manufacture of injectable drugs, and in particular for the aseptic fill & finish of new biotechnology drugs, such as cell therapy, gene therapy or therapeutic vaccines.